SCHEMBL5653336

SCHEMBL5653336

COC(=O)c1ccc(CCNC(=O)[C@H](CCCNC(=O)[C@H](O)Cc2ccccc2)NC(=O)c2cc3ccccc3o2)cc1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGER4 P35408 3/20 0.55
MMP8 P22894 1/20 0.47
MEN1 O00255 3/20 0.47
KMT2A Q03164 3/20 0.47
NPC1 O15118 3/20 0.47
RAB9A P51151 2/20 0.47
NAMPT P43490 1/20 0.45
TACR2 P21452 1/20 0.45
TAS1R3 Q7RTX0 3/20 0.44
TAS1R1 Q7RTX1 3/20 0.44
MCHR1 Q99705 1/20 0.44
KDM4E B2RXH2 1/20 0.43
ACKR3 P25106 1/20 0.41
OPRM1 P35372 1/20 0.41
OPRK1 P41145 1/20 0.41
TMEM97 Q5BJF2 1/20 0.41
SIGMAR1 Q99720 1/20 0.41
MGLL Q99685 1/20 0.41
ALDH1A1 P00352 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5668471 1.00 PTGER4 (0.55) PTGER4MMP8MEN1KMT2ANPC1
SCHEMBL5668462 1.00 PTGER4 (0.55) PTGER4MMP8MEN1KMT2ANPC1
SCHEMBL5655307 0.91 PTGER4 (0.55) PTGER4MMP8MEN1KMT2ANPC1
SCHEMBL5653410 0.91 PTGER4 (0.55) PTGER4MMP8MEN1KMT2ANPC1
SCHEMBL5654830 0.91 PTGER4 (0.56) PTGER4MMP8MEN1KMT2ANPC1
SCHEMBL5655302 0.90 PTGER4 (0.55) PTGER4MEN1KMT2ANPC1RAB9A
SCHEMBL5653405 0.90 PTGER4 (0.55) PTGER4MEN1KMT2ANPC1RAB9A
SCHEMBL5651439 0.90 PTGER4 (0.58) PTGER4MMP8MEN1KMT2ANPC1
SCHEMBL5653684 0.88 PTGER4 (0.72) PTGER4MMP8NAMPTTAS1R3TAS1R1
SCHEMBL5653199 0.88 PTGER4 (0.52) PTGER4MMP8MEN1KMT2ANPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070142638-A1 Ornithine derivatives as prostaglandin e2 agonists or antagonists ASTELLAS PHARMA INC. (JP) 2007-06-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070142638-A1 Ornithine derivatives as prostaglandin e2 agonists or antagonists PTGER4, OXER1, RXFP4 PTGER4 1/4885MMP8 4177/4885MEN1 4001/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.